Breakthrough therapies offer new hope for treating psychopathy

Psychopathy has long been seen as one of the hardest personality disorders to treat. Those affected often struggle with empathy, guilt, and emotional recognition, making traditional therapies ineffective. But recent research and new programmes suggest that change may be possible—even for a condition once considered untreatable.

Psychopathy affects around 1% of the general population but is linked to a large share of violent crime. People with the disorder often display a lack of remorse, shallow emotions, and a manipulative charm. They also struggle to recognise fear or distress in others, which makes standard therapies difficult to apply.

Early attempts to treat psychopathy had little success. Generic cognitive behavioural therapy (CBT) and punishment-based programmes, used before 2020, failed to address the core emotional deficits. As a result, many experts believed the disorder was resistant to treatment, reinforcing stigma and pessimism.

More recent approaches, however, have shown better results. For adolescents with psychopathic traits, two methods now have scientific backing. The Modular Adaptive Callous-Unemotional (MACH) treatment, tested in a 2022 trial, used tailored CBT modules to improve emotion recognition and empathy. Another method, intensive Parent Management Training (PMT) combined with emotion-focused therapy, was supported by a 2023 review showing moderate improvements in behaviour. These newer techniques differ from older ones by directly targeting emotional processing.

For adults, dialectical behaviour therapy and mentalisation-based treatment have helped reduce harmful behaviours in those with borderline and antisocial personality disorders. Prison-based cognitive behavioural programmes have also led to modest drops in reoffending, though success varies. In the UK, the Building Choices initiative has shown early promise in cutting repeat offences, though its long-term impact remains under study.

The shift from broad, one-size-fits-all therapies to more specialised interventions marks a turning point. Research now suggests that psychopathy, while still challenging, may not be as untreatable as once thought. As new methods develop, the focus remains on adapting treatments to the unique emotional and cognitive patterns of the disorder.